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The subject of this review is a process once thought by
many to be nonexistent. Spurred by an early observation
that pyrimidine dimers introduced into mtDNA were not
repaired (Clayton et al. 1974), many people stampeded
to the conclusion that mammalian mitochondria were
incapable of repairing their DNA. Proponents of this
view held that damaged mtDNA molecules might be
either targeted for destruction or diluted out in the cell’s
pool of thousands of undamaged molecules. Perhaps
wastage of an occasional damaged 16-kb DNA molecule
would be a small price to pay to avoid duplication of
the DNA-repair tool chest inside mitochondria. This
careless disregard of DNA maintenance would be ex-
pected to contribute to the incidence of human diseases
involving mtDNA mutations that compromise mito-
chondrial function.
Although these considerations may apply to some
types of mtDNA damage, we now know that other types
of damage occur too frequently to go unrepaired; these
include spontaneous base loss, giving rise to abasic sites
(also referred to as “AP sites” [for “apurinic/apyrimi-
dinic sites”]), and certain key examples of endogenous
damage to DNA bases. It is instructive to consider
mtDNA damage and its potential repair in light of the
repair pathways described for bacterial and eukaryotic
nuclear DNA. In those genomes, most types of DNA
damage are processed by one of three general mecha-
nisms described in table 1. In each case, DNA repair
consists of two coupled steps, involving (1) recognition
of damage and (2) synthesis of a repair patch. Recog-
nition and resection of a lesion from DNA are rate-
limiting steps in repair. For the purposes of this review,
it is appropriate to consider that the three repair pro-
cesses highlighted in table 1 require distinct sets of pro-
teins for lesion recognition—an oversimplification, since
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certain proteins may act in more than one repair path-
way. This article will review the classes of DNA damage
that are amenable to repair in mtDNA, the current un-
derstanding of the enzymatic machinery available for
DNA repair in mitochondria, and the implications that
human mtDNA-repair mechanisms have for aging and
for mitochondrial disease. The emerging pattern is that
mitochondria in higher organisms are reasonably well
equipped to conduct base-excision repair (BER) but ap-
pear to be deficient in nucleotide-excision repair (NER)
and mismatch repair (MMR).
Mitochondria CAN Repair Some DNA Damage
The classical experiment to document DNA repair is
to treat cells with DNA-damaging agents and monitor
the kinetics with which DNA is repaired. If the damage
does not introduce DNA breaks, samples can be treated
with a damage-specific nuclease to monitor the persist-
ence of endonuclease-sensitive sites. In the early days of
DNA-repair research, such experiments used alkaline
elution and alkaline sucrose gradient sedimentation to
monitor the size of DNA fragments after DNA damage.
These techniques were not widely applied to the study
of mtDNA repair, because of the small quantities of
mtDNA in somatic cells. The application of Southern
blot hybridization methods to the study of repair of spe-
cific DNA sequences (Bohr et al. 1985) made it possible
to study the repair of mtDNA in the presence of con-
taminating nuclear DNA. Work from several laborato-
ries has shown that mtDNA damage caused by some
oxidizing agents and alkylating agents can be repaired
(Myers et al. 1988; Satoh et al. 1988; Pettepher et al.
1991; Driggers et al. 1993). In contrast, no repair has
been reported for larger alkylating groups, such as N-7
butyl adducts or bulky adducts such as benz(a)pyrene
diolepoxide, aflatoxin, or psoralen (Backer and Wein-
stein 1980; Niranjan et al. 1982; Cullinane and Bohr
1998). The situation is more complex for some agents
that cause chemically heterogeneous lesions. It has been
reported that some damage introduced into mtDNA by
bleomycin and 4-nitroquinoline oxide can be repaired,
whereas some lesions may be refractory to repair (Sny-
derwine and Bohr 1992; Shen et al. 1995). Similarly,
only interstrand cross-links introduced by cis-platinum
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Table 1
Simplified View of Nuclear DNA–Repair Pathways: Extent of Duplication in Mitochondria
Repair
Process Lesions Processed Proteins Acting in Nuclear DNA Repair Genetic Correlations
BER Spontaneous AP sites;
glycosylase products
Short patch (AP endonuclease, DNA pol b, DNA ligase I/ III);
long patch (AP endonuclease, DNA pol d [or e], FEN1, prolif-
erating-cell nuclear antigen, replication factor C, DNA ligase
I/ III)
Mouse knockouts of AP endonu-
clease, DNA pol b, and DNA
ligase I embryonic lethal
NER Pyrimidine dimers;
bulky chemical
adducts
16 proteins for excision (XPA, XPC [p125, p58], RPA [p70, p34,
p11], TFIIH [XPB/ERCC3, XPD/ERCC2, p62, p44, cdk7/p41,
cycH/p38, 34], XPF 9 [p112, p33], XPG); gap filling (DNA pol
e, proliferating-cell nuclear antigen, replication factor C [6 su-
bunits], DNA ligase I/III)
Xeroderma pigmentosum (al-
leles XPA–XPG); Cockayne
syndrome;
trichothiodystrophy
MMR Base mismatches; short
insertions/deletions
Multiple mut-S and mut-H homologues; excision activities; prolif-
erating-cell nuclear antigen; replication factor C; DNA pol d
Hereditary nonpolyposis colon
cancer
(cis-Pt) are repaired; but common intrastrand cross-links
persist in mtDNA (Singh and Maniccia-Bozzo 1990;
LeDoux et al. 1992). Some of the DNA-damaging agents
used in these studies, such as bleomycin and cis-Pt, are
administered to patients as cytotoxic chemotherapeutic
agents, but the extent to which these treatments affect
the structure of mtDNA in cancer survivors is largely
unexplored.
Virtually all cases cited above in which mtDNA repair
has been documented involve oxidative damage or al-
kylation, classes of DNA damage that also occur by
endogenous mechanisms (Lindahl 1993). Oxidative
damage is of particular relevance to mtDNA, since a
large fraction of reactive oxygen species (ROS) in cells
is thought to originate by leakage of electrons from the
electron-transport system. The proximity of mtDNA to
the ROS generator suggests that there may be a high
rate of endogenous oxidative damage to mtDNA (Shi-
genaga et al. 1994). Some of the immediate products of
ROS damage would include 8-oxo-guanine and thymine
glycol as examples of base damage, as well as malon-
dialdehyde and other products of oxidation of the de-
oxyribose backbone. However, it is difficult to measure
these lesions with confidence, given the small amount
of mtDNA available in cells. The incidence of base dam-
age has generally been measured by high-performance
liquid-chromatography analysis of hydrolyzed DNA;
DNA-backbone damage can be assessed by PCR. An
early study reported a significantly higher incidence of
8-oxo-dG in mtDNA than in nuclear DNA (Richter et
al. 1988). 8-oxo-dG is of particular interest, since it has
been well documented to lead to GrT transversions in
DNA (Grollman and Moriya 1993). An initial report of
high steady-state levels of 8-oxo-dG in the absence of
oxidative stress has not been confirmed by other studies.
The authors of the original report now acknowledge that
contaminants may have caused them to overestimate the
prevalence of this adduct (Helbock et al. 1998). If it is
assumed that the lower steady-state incidence of these
lesions is correct, then mitochondrial repair mechanisms
would appear to be quite efficient at repairing the dam-
age caused by ROS.
Enzymology of BER of mtDNA
As noted in table 1, the BER pathway processes abasic
sites that have been generated either by spontaneous base
loss or by enzymatic removal of bases by damage-specific
glycosylases. The spectrum of base damage that can be
repaired in mtDNA is sure to be limited by the collection
of DNA glycosylases found in the organelle. Unfortu-
nately, our present knowledge of the DNA glycosylase
genes encoded in the human nuclear genome is still very
incomplete, so it is uncertain how many genes encode
either dedicated mitochondrial glycosylases or mito-
chondrially targeted isoforms of such enzymes. DNA
glycosylases are relatively well understood in bacteria,
where the recent sequencing of whole bacterial genomes
is providing a wealth of information on these gene fam-
ilies. Table 2 provides a list of several well-characterized
DNA glycosylases in Escherichia coli and the current
understanding of their human homologues.
The prototypical DNA glycosylase, uracil DNA gly-
cosylase (UDG), is directed to either nuclei or mito-
chondria by differential splicing (Slupphaug et al. 1993).
Only during the past few years have other glycosylases
have come under study in higher eukaryotes. Some pro-
gress has been made in following the UDG model by
analysis of candidate genes that appear to encode DNA
glycosylases with potential N-terminal mitochondrial lo-
calization signals (MLSs). This is done first by computer
sequence analysis and subsequently by testing the ability
of these N-terminal sequences to direct a reporter gene
(such as green fluorescent protein [GFP]) to mitochon-
dria. As shown in table 2, there is strong evidence to
suggest that mitochondria contain 8-oxo-guanine gly-
cosylase (OGG) (Nishioka et al., in press). The N-termini
of other glycosylase genes—including hNTH1, hMYH,
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Table 2
mtDNA Glycosylases: Relation to Nuclear Homologues of Bacterial Enzymes
E. coli Enzymea
Human
Homologue
Potential
MLS?b Protein Documented in Mitochondria?
UDG, ung UDG Yes (t) Yes, by Slupphaug et al. (1993)
Thymine glycol glycosylase, endonuclease III, nth hNTH Yes (t) Not determined
Formamidopyrimidine glycosylase, FAPY glycosylase, mut-m OGG Yes (t) Yes, by Nishioka et al. (in press)
AG glycosylase, mut-Y hMYH Yes (t) Not determined
Alkyl adenine glycosylase, aag MAG, AAG Yes (c) Not determined
a Several glycosylases have been shown to act on more than one type of modified base.
b “(t)” denotes that the MLS has been tested for its ability to direct a reporter protein to mitochondria; “(c)” denotes that the signal has
been identified only by computerized sequence analysis.
and AAG—appear to encode potential MLSs, and the
first two of these have been shown to function to direct
GFP to mitochondria (Takao et al. 1998). It is interesting
to note that the human homologue of another enzyme
(albeit not a glycosylase) involved in the response to
oxidative damage—that is, human 8-oxo-dGTPase (a
homologue of the bacterial mutT)—has also been iden-
tified in mitochondria (Kang et al. 1995). Thus, it seems
likely that mitochondria contain all of the components
of the so-called GO system of E. coli, which responds
to oxidative damage to guanosine either as a free nu-
cleotide or within DNA (Grollman and Moriya 1993).
The data in table 2 are almost certainly incomplete; other
enzyme activities are only now being investigated (Cro-
teau et al. 1997), and many others remain to be
explored.
The existence of DNA glycosylases and the unavoid-
able spontaneous formation of abasic sites in mtDNA
suggests that the mitochondria should maintain a com-
plete system for repair of abasic sites. Since my labo-
ratory has been characterizing the mitochondrial repli-
cative DNA pol g, my colleagues and I undertook to
purify other enzymes that might cooperate with this en-
zyme in the repair of abasic sites in mtDNA. By analogy
to BER in bacterial and nuclear systems, this repair was
expected to require at least three other enzymatic activ-
ities—those of an AP endonuclease, an AP lyase, and a
DNA ligase (fig. 1). Although we succeeded in recon-
stituting BER with mitochondrial enzymes (Pinz and Bo-
genhagen 1998), a great deal remains to be learned con-
cerning the enzymes that can act in this pathway, as
discussed below.
AP Endonuclease
Despite the frequency and importance of abasic sites
in mtDNA, we are still largely ignorant of AP endonucle-
ases in mitochondria. From our work with Xenopus en-
zymes and from a previous study using mouse cells
(Tomkinson et al. 1988), it appears that the mitochon-
drial AP endonuclease cleaves on the 5′ side of the AP
site and behaves as a single chromatographic species.
The mitochondrial enzymes have not yet been cloned,
but Tomkinson et al. (1988) and Pinz and Bogenhagen
(1998, and unpublished data) have found that antisera
raised against the nuclear enzyme cross-react with pro-
teins in preparations of mouse and Xenopus mitochon-
drial AP endonuclease.
DNA pol g
DNA pol g is capable of binding the 3′-OH group
produced by AP endonuclease to fill a one-nucleotide
gap. The Xenopus enzyme was found to contain an ad-
ditional activity as an AP lyase (Pinz and Bogenhagen
1998), which was subsequently confirmed for the re-
combinant human DNA pol g (Longley et al. 1998).
Although this represents the second example of a DNA
polymerase that can act as an AP lyase activity, the cor-
responding activity previously identified in DNA pol b
has a much higher catalytic activity (Matsumoto and
Kim 1995). DNA polymerases related to E. coli DNA
polymerase I and T7 DNA polymerase also contain an
AP lyase activity with a low turnover capacity (K. G.
Pinz and D. F. Bogenhagen, unpublished data). DNA pol
g is a heterodimeric protein whose larger subunit con-
tains the catalytic activities for the polymerase, 3′–5′
proofreading exonuclease, as well as for the newly dis-
covered AP lyase activity. The smaller subunit acts as a
processivity factor (Carrodeguas et al. 1999) but is not
required for gap-filling synthesis in vitro (Longley et al.
1998; K. G. Pinz and D. F. Bogenhagen, unpublished
data).
mtDNA Ligase
The final step in the BER pathway is the resealing of
the DNA by DNA ligase. To date, all DNA ligases char-
acterized in eukaryotes are ATP-dependent enzymes that
act through an enzyme-adenylate intermediate to reseal
single-strand breaks. mtDNA ligase has been purified
from Xenopus oocyte mitochondria as an ∼100-kD pro-
tein active in an adenylation assay (Pinz and Bogenhagen
1998). The enzyme has been shown to be clearly distinct
from DNA ligase I, which is the predominant source of
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Figure 1 Common pathway for BER. The sequence context
shown is appropriate for repair of a uracil residue in DNA, initiated
by action of UDG. A single BER pathway has been documented for
repair of bacterial DNA, for the nuclear pol b–dependent pathway
and for mtDNA repair. An alternative long patch repair pathway,
dependent on proliferating-cell nuclear antigen, also exists for eukar-
yotic nuclear DNA “dRP” denotes the deoxyribose phosphate group
excised from the DNA. The complementary strand of the DNA duplex
is not shown. (For other details, see the text.)
ligase activity in Xenopus oocytes. My colleagues and I
have noted that, in published cDNA sequences of human
DNA ligase III and IV (Wei et al. 1995), each of these
gene products could be translated from in-frame initi-
ation codons that were upstream of those indicated in
the initial reports. Remarkably, in each case, the up-
stream sequences revealed a potential N-terminal MLS,
suggesting that alternative translational initiation could
generate both a mitochondrial and a nuclear isoform of
each of these enzymes. Indeed, when we cloned cDNAs
encoding Xenopus DNA ligase III and IV, we found that
the putative MLS regions were conserved in these genes
and that the putative MLS regions of DNA ligase III can
direct GFP to mitochondria (R. M. Perez-Jannotti, S. M.
Klein, and D. F. Bogenhagen, unpublished data). More-
over, an antiserum raised against a DNA ligase
III–specific epitope was found to cross-react with the
mtDNA ligase. Although protein sequence data or other
definitive proof that mtDNA ligase is a product of the
DNA ligase III gene is lacking, it is likely that the DNA
ligase III gene will join the collection of DNA glycosylase
genes described above, as a dual-function gene capable
of providing enzyme to both the mitochondrion and the
nucleus. When DNA ligase III resides in the nucleus, it
acts in association with the XRCC1 gene product that
has not yet been shown to enter mitochondria. It is un-
known whether the mitochondrial isoform acts on its
own or has a molecular partner in place of XRCC1. It
is also uncertain whether DNA ligase IV may enter mi-
tochondria in some cells. Since mtDNA ligase was pu-
rified by use of an adenylation assay, and since DNA
ligase IV has been reported to purify in an adenylated
form that is not efficiently labeled in vitro, it is possible
that a mitochondrial form of DNA ligase IV may have
been overlooked because of the use of the adenylation
assay. In the mouse, DNA ligase IV is an essential gene
(Frank et al. 1998); whether mitochondrial abnormali-
ties contribute to the demise of DNA ligase IV knockout-
mouse embryos is unknown.
mtDNA Repair as a Problem in Cell Biology
Although many proteins involved in repair and main-
tenance of mtDNA remain to be discovered, several ex-
amples of repair proteins that are produced from dual-
function genes that contribute products to both the nu-
cleus and mitochondria have already been identified.
This type of organization is not unprecedented, since a
number of proteins involved in tRNA processing have
been shown to be products of dual-function genes (Mar-
tin and Hopper 1994). It is appropriate to ask both how
the expression of proteins such as UDG, OGG1, and
DNA ligase III is controlled to suit the needs of both
organelles and how this regulation varies in different cell
types. One can envision circumstances in which the sup-
ply of repair proteins to mitochondria may be either
excessive or insufficient. In the case of UDG, ∼25% of
the total activity in a cell is directed to mitochondria,
which contain only 0.1% of the cell’s DNA. Thus, rel-
ative to the nucleus, mitochondria contain a large excess
of this enzyme scanning DNA for misincorporated U
residues. Because some glycosylases have a propensity
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to remove normal bases at a measurable efficiency, and
because the overexpression of at least one member of
these enzymes is mutagenic (Berdal et al. 1998), it is
possible that delivering too much of a repair glycosylase
to mitochondria may be detrimental. Conversely, it is
possible that, in postreplicative cells, which may be ex-
pected to reduce their expression of repair and repli-
cation factors, mitochondria could become depleted of
these factors. This could contribute to problems in
mtDNA maintenance during aging, since muscle- and
nerve-cell mitochondria continue to require nuclear-gene
products to repair and replace their DNA.
Does Deficiency in Mitochondrial NER or MMR
Contribute to Human Mitochondrial Disease?
This review has concentrated on BER of mtDNA as
the one example of a repair pathway that does seem to
function in mitochondria. As summarized above, there
is little evidence that NER functions in mitochondria to
remove bulky DNA adducts. NER of nuclear DNA re-
quires a large collection of proteins (including the al-
phabet soup of XP and ERCC genes; see table 1), most
of which probably have no access to mtDNA. This de-
ficiency in NER is striking, in the face of extensive ev-
idence that many chemical carcinogens form adducts
with mtDNA, at frequencies often 10–50-fold higher
than they do with nuclear DNA. In the case of chemical
damage to mtDNA, the rate of accumulation of dam-
aged bases and the fate of damaged DNA molecules have
not been studied in detail. If these lesions are not
removed, they will be encountered by DNA pol g and
mtRNA polymerase in the course of replication and tran-
scription and will likely block both processes. Deletions
or rearrangements may result when a DNA pol g mol-
ecule is stalled at a bulky lesion. This model represents
a plausible, if speculative, mechanism whereby unre-
paired bulky damage to mtDNA may contribute to mi-
tochondrial mutagenesis. However, damage to mtDNA
by exogenous chemicals does not appear to cause a high
rate of fixation of mutations (Mita et al. 1988). It may
be that most mtDNA molecules bearing bulky damage
are indeed targeted for destruction, perhaps by a turn-
over mechanism that uses an arrested polymerase as a
signal to promote degradation. More research on the
fate of damaged mtDNA molecules is required for res-
olution of these issues.
The suggestion in this review—that is, that mito-
chondria in higher organisms are deficient in mismatch
repair—is also largely speculative. Saccharomyces cer-
evisiae maintains a mut-S homologue, msh-1, and mu-
tations in msh-1 induce a high rate of mtDNA mutations
(Reenan and Kolodner 1992; Vanderstraeten et al.
1998). However, a complete MMR pathway in yeast
mitochondria has not yet been described. The presence
of an active MMR system in yeast may help explain the
lower rate of evolutionary change in yeast mtDNA ge-
nomes as compared with those in higher eukaryotes. A
mitochondrial mut-S gene is retained in a coral mtDNA
genome (Pont-Kingdon et al. 1995) but not in other
metazoans. No available evidence indicates that themut-
S or mut-L homologues of higher eukaryotes have access
to mitochondria, but this lack of data may be seen as a
challenge—to nucleic-acid biochemists, cell biologists,
and geneticists—to show that MMR does indeed occur
in mitochondria in higher organisms.
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